Akanda Corp (AKAN) has released an update.
Akanda Corp, an international medical cannabis company, has successfully regained compliance with Nasdaq’s Minimum Bid Price Requirement after its share price consistently closed at $1.00 or higher for 10 consecutive business days. This recovery follows a previous notification of non-compliance from Nasdaq when the company’s share price fell below the required minimum. Akanda’s operations include a UK-based pharmaceutical distributor and plans to develop THC and CBD facilities in Canada.
For further insights into AKAN stock, check out TipRanks’ Stock Analysis page.